Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Richard Tobin

Concepts (207)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Richard Tobin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Richard Tobin has written about over time.
Antigens, Differentiation, B-Lymphocyte, 4 publications between 2010 and 2017, average publication date June 2014. Brain Injuries, 1 publications between 2014 and 2014, average publication date October 2014. Neurodegenerative Diseases, 1 publications between 2014 and 2014, average publication date October 2014. Pre-Eclampsia, 3 publications between 2013 and 2017, average publication date February 2015. Histocompatibility Antigens Class II, 5 publications between 2010 and 2019, average publication date July 2015. Lymphocyte Activation, 4 publications between 2010 and 2020, average publication date October 2015. Tumor Escape, 2 publications between 2017 and 2017, average publication date January 2017. T-Lymphocyte Subsets, 4 publications between 2014 and 2024, average publication date July 2018. Antineoplastic Agents, Immunological, 1 publications between 2018 and 2018, average publication date August 2018. Spleen, 4 publications between 2014 and 2022, average publication date October 2018. Ipilimumab, 2 publications between 2018 and 2019, average publication date December 2018. Neoplasms, 3 publications between 2017 and 2024, average publication date May 2019. Myeloid-Derived Suppressor Cells, 5 publications between 2017 and 2024, average publication date January 2020. Antineoplastic Combined Chemotherapy Protocols, 2 publications between 2018 and 2023, average publication date December 2020. Tretinoin, 2 publications between 2018 and 2023, average publication date December 2020. Melanoma, 7 publications between 2018 and 2024, average publication date July 2021. Neoplasms, Second Primary, 1 publications between 2023 and 2023, average publication date April 2023. Skin Neoplasms, 3 publications between 2021 and 2024, average publication date July 2023. CD8-Positive T-Lymphocytes, 3 publications between 2023 and 2024, average publication date September 2023. Hematologic Neoplasms, 1 publications between 2024 and 2024, average publication date January 2024.

To see the data from this visualization as text, click here.
Tobin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)